| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
American Health Foundation [B. R., S. B.] and New York Medical College [B. R., A. E.], Valhalla, New York 10595; Strang Cancer Prevention Center, New York, New York 10021 [S. B., H. S., N. K., M. L.]; G. Genimatas Hospital, Athens, Greece [V. B., Z. M.]; and Veterans Affairs Medical Center, Salt Lake City, Utah 84148 [M. G.]
DNA-dependent protein kinase (DNA-PK), consisting of a catalytic subunit (DNA-PKcs) and the Ku70 and Ku86 proteins, participates in the repair of DNA double-strand breaks (DSBs). We assessed its expression immunohistochemically in normal human colon tissue, colon adenomas, colon carcinomas, and normal tissue distant from carcinomas. Normal colonocytes expressed all DNA-PK proteins. Compared with the expression in normal tissue [176.62 ± 18.56 (the intensity of expression x the percentage of cells expressing this protein), mean + SE], the expression of Ku70 was significantly reduced in adenomas (36.62 ± 11.09; P < 0.001) and carcinomas (85.68 ± 15.76; P < 0.01), as was the expression of Ku86 [(113.10 ± 10.22 versus 41.66 ± 14.71 in adenomas (P < 0.01) or versus 85.68 ± 15.76 in carcinomas (P < 0.05)]. The expression of DNA-PKcs was not significantly changed. The marked underexpression of Ku70 and Ku86 starting at the adenoma stage may be crucial to the development of colon cancer.
This article has been cited by other articles:
![]() |
M. Idogawa, M. Masutani, M. Shitashige, K. Honda, T. Tokino, Y. Shinomura, K. Imai, S. Hirohashi, and T. Yamada Ku70 and Poly(ADP-Ribose) Polymerase-1 Competitively Regulate {beta}-Catenin and T-Cell Factor-4-Mediated Gene Transactivation: Possible Linkage of DNA Damage Recognition and Wnt Signaling Cancer Res., February 1, 2007; 67(3): 911 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Parrella, P Mazzarelli, E Signori, G Perrone, G F Marangi, C Rabitti, M Delfino, M Prencipe, A P Gallo, M Rinaldi, et al. Expression and heterodimer-binding activity of Ku70 and Ku80 in human non-melanoma skin cancer J. Clin. Pathol., November 1, 2006; 59(11): 1181 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kennedy and A. D. D'Andrea DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes J. Clin. Oncol., August 10, 2006; 24(23): 3799 - 3808. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sturgeon, Z. A. Knight, K. M. Shokat, and M. Roberge Effect of combined DNA repair inhibition and G2 checkpoint inhibition on cell cycle progression after DNA damage. Mol. Cancer Ther., April 1, 2006; 5(4): 885 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grabsch, M. Dattani, L. Barker, N. Maughan, K. Maude, O. Hansen, H. E. Gabbert, P. Quirke, and W. Mueller Expression of DNA Double-Strand Break Repair Proteins ATM and BRCA1 Predicts Survival in Colorectal Cancer Clin. Cancer Res., March 1, 2006; 12(5): 1494 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dumon-Jones, P.-O. Frappart, W.-M. Tong, G. Sajithlal, W. Hulla, G. Schmid, Z. Herceg, M. Digweed, and Z.-Q. Wang Nbn Heterozygosity Renders Mice Susceptible to Tumor Formation and Ionizing Radiation-Induced Tumorigenesis Cancer Res., November 1, 2003; 63(21): 7263 - 7269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueda, T. Mineta, K. Suzuyama, M. Furuta, T. Shiraishi, and K. Tabuchi Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis Neuro-oncol, January 1, 2003; 5(1): 14 - 18. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |